HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia

International Journal of Cancer

Volumn 78, Issue 3, 1998, Pages 281-285

  Ho, Gloria Y F ^a   Kadish, Anna S ^a   Burk, Robert D ^a   Basu, Jayasri ^a   Palan, Prabhudas R ^a   Mikhail, Magdy ^a   Romney, Seymour L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; RETINOL;

ADULT; AGE; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RISK; CIGARETTE SMOKING; CONDOM; EDUCATION; ETHNOLOGY; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SEXUAL BEHAVIOR; UTERINE CERVIX CARCINOMA IN SITU; VIRUS LOAD; VITAMIN BLOOD LEVEL; WART VIRUS;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONDOMS; EDUCATIONAL STATUS; ETHNIC GROUPS; FEMALE; HUMANS; NEOPLASM STAGING; NEW YORK CITY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SEXUAL BEHAVIOR; SMOKING; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0032578716     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981029)78:3<281::AID-IJC3>3.0.CO;2-R     Document Type: Article

References (21)

1. BASU, J., MIKHAIL, M.S., PAYRAUDEAU, P.H., PALAN, P.R. and ROMNEY, S.L., Smoking and the antioxidant ascorbic acid: plasma, leukocyte, and cervicovaginal cell concentrations in normal healthy women. Amer. J. Obstet. Gynecol., 163, 1948-1952 (1990).
2. BECKER, T.M., WHEELER, C.M., MCGOUGH, N.S., PARMENTER, C.A., STIDLEY, C.A., JAMISON, S.F. and JORDAN, S.W., Cigarette smoking and other risk factors for cervical dysplasia in southwestern Hispanic and non-Hispanic white women. Cancer Epidemiol. Biomarkers Prevent., 3, 113-119 (1994).
3. BEGRENS, W.A. and MADERE, R., A highly sensitive high performance liquid chromatography method for the estimation of ascorbic and dehydroascorbic acid in the tissues, biological fluids, and foods. Anal. Biochem., 165, 102-107 (1987).
4. BOSCH, F.X., MANOS, M.M., MUÑOZ, N., SHERMAN, M., JANSEN, A.M., PETO, J., SCHIFFMAN, M.H., MORENO, V., KURMAN, R. and SHAH, K.V., Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J. nat. Cancer Inst., 87, 796-802 (1995).
5. BURK, R.D., HO, G.Y.F., BEARDSLEY, L., LEMPA, M., PETERS, M. and BIERMAN, R., Sexual behavior and partner characteristics are the predominant risk factors for genital HPV infection in young women. J. infect. Dis., 174, 679-689 (1996).
6. HILDESHEIM, A., SCHIFFMAN, M.H., GRAVITT, P.E., GLASS, A.G., GREER, C.E., ZHANG, T., SCOTT, D.R., RUSH, B.B., LAWLER, P., SHERMAN, M.E., KURMAN, R.J. and MANOS, M.M., Persistence of type-specific human papillomavirus infection among cytologically normal women. J. INFECT. DIS., 169, 235-240 (1994).
7. HO, G.Y.F., BIERMAN, R., BEARDSLEY, L., CHANG, C.J. and BURK, R.D., Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med., 338, 423-428 (1998a).
8. HO, G.Y.F., BURK, R.D., KLEIN, S., KADISH, A.S., CHANG, C.J., PALAN, P., BASU, J., TACHEZY, R., LEWIS, R. and ROMNEY, S., Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. nat. Cancer Inst., 87, 1365-1371 (1995).
9. HO, G.Y.F., PALAN, PR., BASU, J., ROMNEY, S.L., KADISH, A.S., MIKHAIL, M., WASSERTHEIL-SMOLLER, S., RUNOWICZ, C. AND BURK, R.D., Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int. J. Cancer (1998b) (In Press).
10. HOLLY, E.A., PETRAKIS, N.L., FRIEND, N.F., SARLES, D.L., LEE, R.E. and FLANDER, L.B., Mutagenic mucus in the cervix of smokers. J. nat. Cancer Inst., 76, 983-986 (1986).
11. KOUTSKY, L.A., HOLMES, K.K., CRITCHLOW, C.W., STEVENS, C.E., PAAVONEN, J., BECKMANN, A.M., DEROUEN, T.A., GALLOWAY, D.A., VERNON, D. and KIVIAT, N.B., A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med., 327, 1272-1278 (1992).
12. NGELANGEL, C., MUÑOZ, N., BOSCH, F.X., LIMSON, G.M., FESTIN, M.R., DEACON, J., JACOBS, M.V., SANTAMARIA, M., MEIJER, C.J.L.M. and WALBOOMERS, J.M.M., Causes of cervical cancer in the Philippines: a case-control study. J. nat. Cancer Inst., 90, 43-49 (1998).
13. PALAN, P.R., MIKHAIL, M.S., BASU, J. and ROMNEY, S.L., Plasma levels of antioxidant β-carotene and α-tocopherol in uterine cervix dysplasias and cancer. Nutr. Cancer, 15, 13-20 (1991).
14. PALEFSKY, J.M. and HOLLY, E.A., Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol. Biomarkers Prevent., 4, 415-428 (1995).
15. PROKOPCZYK, B., COX, J.E., HOFFMANN, D. and WAGGONER, S.E., Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J. nat. Cancer Inst., 89, 868-873 (1997).
16. ROMNEY, S.L., HO, G.Y.F., PALAN, P.R., BASU, J., KADISH, A.S., KLEIN, S., MIKHAIL, M., HAGAN, R.J., CHANG, C.J. and BURK, R.D., Effects of β-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection. Gynecol. Oncol., 65, 483-492 (1997).
17. SCHIFFMAN, M.H., BAUER, H.M., HOOVER, R.N., GLASS, A.G., CADELL, D.M., RUSH, B.B., SCOTT, D.R., SHERMAN, M.E., KURMAN, R.J., WACHOLDER, S., STANTON, C.K. and MANOS, M.M., Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. nat. Cancer Inst., 85, 958-964 (1993).
18. SIMONS, A.M., VAN HERCKENRODE, C.M., RODRIGUEZ, J.A., MAITLAND, N., ANDERSON, M., PHILLIPS, D.H. and COLEMAN, D.V., Demonstration of smoking-related DNA damage in cervical epithelium and correlation with human papillomavirus type 16, using exfoliated cervical cells. Brit. J. Cancer, 71, 246-249 (1995).
19. STATACORP, Stata statistical software: release 5.0, Stata Press, College Station, TX (1997).
20. SYRJÄNEN, K., KATAJA, V., YLISKOSKI, M., CHANG, F., SYRJÄNEN, S. and SAARIKOSKI, S., Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda system. Obstet. Gynecol., 79, 675-682 (1992).
21. THIERRY, F., HPV proteins in the control of HPV transcription. In: C. Lacey (ed.), Papillomavirus reviews: current research on papillomaviruses, pp. 21-29, Leeds University Press, Leeds (1996).